evidence table
Cocoa Blood Pressure Randomized Trial Evidence Table
Structured evidence table for Cocoa Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Cocoa Blood Pressure Randomized Trial | MetS is a multifactorial condition, with its primary indicators including obesity, hypertension, dyslipidemia, insulin resistance, and hyperglycemia; i.e., a patient who possesses at least 3 of the following parameters is designated with MetS: glucose intolerance, increased levels of triglycerides, augmented waist circumference, low levels of high-density lipoprotein cholesterol (HDL-c), and hypertension [,,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cocoa Blood Pressure Randomized Trial | It is possible to develop a close relationship with MetS, metabolic dysfunction-associated steatotic liver disease (MASLD), and CVD [,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cocoa Blood Pressure Randomized Trial | MASLD is strongly associated with various conditions, including MetS, and is characterized by the persistence of a chronic inflammatory state detrimental to the organism [,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cocoa Blood Pressure Randomized Trial | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Metabolic disorders are increasing sharply due to severe modifications in lifestyle [,,,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cocoa Blood Pressure Randomized Trial | Recent randomized trials and longitudinal studies report modest but reproducible benefits on cognitive domains and vascular/endothelial function with berry/grape extracts, matcha/green tea, and high-polyphenol extra-virgin olive oil; effects appear stronger in older adults or those with metabolic risk. | 4 | Akif A (2026) | Dietary Polyphenols in Non-Communicable Chronic Diseases: Neuro-Enteric Mechanisms, Multi-Omics Biomarkers and Translational Opportunities. |
| Cocoa Blood Pressure Randomized Trial | Complementary evidence in irritable bowel syndrome (IBS)-a prototypical gut-brain disorder-suggests polyphenol-based combinations (often with probiotics/fiber) can improve quality of life and inflammatory markers, supporting enteric-central crosstalk. | 4 | Akif A (2026) | Dietary Polyphenols in Non-Communicable Chronic Diseases: Neuro-Enteric Mechanisms, Multi-Omics Biomarkers and Translational Opportunities. |
| Cocoa Blood Pressure Randomized Trial | Polyphenols from plant foods (tea, cocoa, berries, grapes, and extra-virgin olive oil) modulate oxidative stress, inflammation, vascular function, and the gut microbiome-axes central to non-communicable chronic diseases (NCCDs) that involve the brain and enteric nervous system (ENS). | 4 | Akif A (2026) | Dietary Polyphenols in Non-Communicable Chronic Diseases: Neuro-Enteric Mechanisms, Multi-Omics Biomarkers and Translational Opportunities. |
Source documents